Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: HEART FAILURE - METABOLISM , . Treffer: 39

2021

Tomin, T; Schittmayer, M; Sedej, S; Bugger, H; Gollmer, J; Honeder, S; Darnhofer, B; Liesinger, L; Zuckermann, A; Rainer, PP; Birner-Gruenberger, R Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts.
Int J Mol Sci. 2021; 22(4): Doi: 10.3390/ijms22041787 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Bugger, H; Pfeil, K Mitochondrial ROS in myocardial ischemia reperfusion and remodeling.
Biochim Biophys Acta Mol Basis Dis. 2020; 1866(7):165768-165768 Doi: 10.1016/j.bbadis.2020.165768
Web of Science PubMed FullText FullText_MUG

 

2018

Fischer, TH; Eiringhaus, J; Dybkova, N; Saadatmand, A; Pabel, S; Weber, S; Wang, Y; Köhn, M; Tirilomis, T; Ljubojevic, S; Renner, A; Gummert, J; Maier, LS; Hasenfuß, G; El-Armouche, A; Sossalla, S Activation of protein phosphatase 1 by a selective phosphatase disrupting peptide reduces sarcoplasmic reticulum Ca²⁺ leak in human heart failure.
Eur J Heart Fail. 2018; 20(12):1673-1685 Doi: 10.1002/ejhf.1297 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Skrabal, F; Pichler, GP; Penatzer, M; Steinbichl, J; Hanserl, AK; Leis, A; Loibner, H The Combyn™ ECG: Adding haemodynamic and fluid leads for the ECG. Part II: Prediction of total body water (TBW), extracellular fluid (ECF), ECF overload, fat mass (FM) and "dry" appendicular muscle mass (AppMM).
Med Eng Phys. 2017; 44(8):44-52 Doi: 10.1016/j.medengphy.2017.03.002
Web of Science PubMed FullText FullText_MUG

 

Wallner, M; Khafaga, M; Kolesnik, E; Vafiadis, A; Schwantzer, G; Eaton, DM; Curcic, P; Köstenberger, M; Knez, I; Rainer, PP; Pichler, M; Pieske, B; Lewinski, DV Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium.
Oncotarget. 2017; 8(30):49264-49274 Doi: 10.18632/oncotarget.17540 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Kooij, V; Viswanathan, MC; Lee, DI; Rainer, PP; Schmidt, W; Kronert, WA; Harding, SE; Kass, DA; Bernstein, SI; Van Eyk, JE; Cammarato, A Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy.
Cardiovasc Res. 2016; 110(2):238-248 Doi: 10.1093/cvr/cvw050 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Ljubojevic, S; Bers, DM Nuclear calcium in cardiac myocytes.
J Cardiovasc Pharmacol. 2015; 65(3):211-217 Doi: 10.1097/FJC.0000000000000174 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mayer, SC; Gilsbach, R; Preissl, S; Monroy Ordonez, EB; Schnick, T; Beetz, N; Lother, A; Rommel, C; Ihle, H; Bugger, H; Rühle, F; Schrepper, A; Schwarzer, M; Heilmann, C; Bönisch, U; Gupta, SK; Wilpert, J; Kretz, O; von Elverfeldt, D; Orth, J; Aktories, K; Beyersdorf, F; Bode, C; Stiller, B; Krüger, M; Thum, T; Doenst, T; Stoll, M; Hein, L Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure.
Circ Res. 2015; 117(7): 622-633. Doi: 10.1161/CIRCRESAHA.115.306721 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Bisping, E; Wakula, P; Poteser, M; Heinzel, FR Targeting cardiac hypertrophy: toward a causal heart failure therapy.
J Cardiovasc Pharmacol. 2014; 64(4):293-305 Doi: 10.1097/FJC.0000000000000126 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bugger, H; Abel, ED Molecular mechanisms of diabetic cardiomyopathy.
Diabetologia. 2014; 57(4): 660-671. Doi: 10.1007/s00125-014-3171-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koller, L; Kleber, M; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, T; Delgado, G; Tomaschitz, A; Pilz, S; März, W; Niessner, A C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2014; 16(7):758-766 Doi: 10.1002/ejhf.104 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Walton, RD; Martinez, ME; Bishop, MJ; Hocini, M; Haïssaguerre, M; Plank, G; Bernus, O; Vigmond, EJ Influence of the Purkinje-muscle junction on transmural repolarization heterogeneity.
Cardiovasc Res. 2014; 103(4):629-640 Doi: 10.1093/cvr/cvu165 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

de Boer, RA; Edelmann, F; Cohen-Solal, A; Mamas, MA; Maisel, A; Pieske, B Galectin-3 in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2013; 15(10):1095-1101 Doi: 10.1093/eurjhf/hft077 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Trescher, K; Hasun, M; Baumgartner, A; Dietl, W; Wolfsberger, M; Hallstrom, S; Podesser, BK; New HTK-N46B cardioplegia provides superior protection during ischemia/reperfusion in failing hearts.
J CARDIOVASC SURG. 2013; 54(3): 413-421.
Web of Science PubMed

 

2012

Larson, JE; Rainer, PP; Watts, VL; Yang, R; Miller, KL; Phan, A; Barouch, LA Dependence of β3-adrenergic signaling on the adipokine leptin in cardiac myocytes.
Int J Obes (Lond). 2012; 36(6):876-879 Doi: 10.1038/ijo.2011.137 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tomaschitz, A; Ritz, E; Pieske, B; Fahrleitner-Pammer, A; Kienreich, K; Horina, JH; Drechsler, C; März, W; Ofner, M; Pieber, TR; Pilz, S Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Cardiovasc Res. 2012; 94(1):10-19 Doi: 10.1093/cvr/cvs092 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Bugger, H; Guzman, C; Zechner, C; Palmeri, M; Russell, KS; Russell, RR Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation.
Cancer Chemother Pharmacol. 2011; 67(6): 1381-1388. Doi: 10.1007/s00280-010-1441-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Knöll, R; Linke, WA; Zou, P; Miocic, S; Kostin, S; Buyandelger, B; Ku, CH; Neef, S; Bug, M; Schäfer, K; Knöll, G; Felkin, LE; Wessels, J; Toischer, K; Hagn, F; Kessler, H; Didié, M; Quentin, T; Maier, LS; Teucher, N; Unsöld, B; Schmidt, A; Birks, EJ; Gunkel, S; Lang, P; Granzier, H; Zimmermann, WH; Field, LJ; Faulkner, G; Dobbelstein, M; Barton, PJ; Sattler, M; Wilmanns, M; Chien, KR Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart.
Circ Res. 2011; 109(7):758-769 Doi: 10.1161/CIRCRESAHA.111.245787 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riehle, C; Wende, AR; Zaha, VG; Pires, KM; Wayment, B; Olsen, C; Bugger, H; Buchanan, J; Wang, X; Moreira, AB; Doenst, T; Medina-Gomez, G; Litwin, SE; Lelliott, CJ; Vidal-Puig, A; Abel, ED PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Circ Res. 2011; 109(7): 783-793. Doi: 10.1161/CIRCRESAHA.111.243964 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Bugger, H; Schwarzer, M; Chen, D; Schrepper, A; Amorim, PA; Schoepe, M; Nguyen, TD; Mohr, FW; Khalimonchuk, O; Weimer, BC; Doenst, T Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure.
Cardiovasc Res. 2010; 85(2): 376-384. Doi: 10.1093/cvr/cvp344 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rohini, A; Agrawal, N; Koyani, CN; Singh, R Molecular targets and regulators of cardiac hypertrophy.
Pharmacol Res. 2010; 61(4):269-280 Doi: 10.1016/j.phrs.2009.11.012
Web of Science PubMed FullText FullText_MUG

 

2009

Heymans, S; Hirsch, E; Anker, SD; Aukrust, P; Balligand, JL; Cohen-Tervaert, JW; Drexler, H; Filippatos, G; Felix, SB; Gullestad, L; Hilfiker-Kleiner, D; Janssens, S; Latini, R; Neubauer, G; Paulus, WJ; Pieske, B; Ponikowski, P; Schroen, B; Schultheiss, HP; Tschope, C; Van Bilsen, M; Zannad, F; McMurray, J; Shah, AM Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2009; 11(2):119-129 Doi: 10.1093/eurjhf/hfn043 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Lechner, E; Schreier-Lechner, EM; Hofer, A; Gitter, R; Mair, R; Biebl, A; Tulzer, G Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
J Thorac Cardiovasc Surg. 2009; 138(3):560-564 Doi: 10.1016/j.jtcvs.2009.03.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

von Lewinski, D; Kockskamper, J; Zhu, D; Post, H; Elgner, A; Pieske, B Reduced Stretch-Induced Force Response in Failing Human Myocardium Caused by Impaired Na+-Contraction Coupling
CIRC-HEART FAIL. 2009; 2(1): 47-55. Doi: 10.1161/CIRCHEARTFAILURE.108.794065 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Bito, V; Heinzel, FR; Biesmans, L; Antoons, G; Sipido, KR Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling.
Cardiovasc Res. 2008; 77(2): 315-324. Doi: 10.1093/cvr/cvm063 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jahns, BG; Stein, W; Hilfiker-Kleiner, D; Pieske, B; Emons, G Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
Am J Obstet Gynecol. 2008; 199(4):e5-e6 Doi: 10.1016/j.ajog.2008.06.051 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

von Lewinski, D; Zhu, D; Khafaga, M; Kockskamper, J; Maier, LS; Hasenfuss, G; Pieske, B Frequency-dependence of the slow force response.
Front Biosci. 2008; 13(4): 7202-7209. Doi: 10.2741/3222
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

von Lewinski, D; Bisping, E; Elgner, A; Kockskämper, J; Pieske, B Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium.
Eur J Heart Fail. 2007; 9(11):1086-1094 Doi: 10.1016/j.ejheart.2007.08.004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Buerger, A; Rozhitskaya, O; Sherwood, MC; Dorfman, AL; Bisping, E; Abel, ED; Pu, WT; Izumo, S; Jay, PY Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.
J Card Fail. 2006; 12(5):392-398 Doi: 10.1016/j.cardfail.2006.03.002
Web of Science PubMed FullText FullText_MUG

 

Doenst, T; Bugger, H; Leippert, S; Barleon, B; Marme, D; Beyersdorf, F Differential gene expression in response to ventricular unloading in rat and human myocardium.
Thorac Cardiovasc Surg. 2006; 54(6): 381-387. Doi: 10.1055/s-2006-924267
Web of Science PubMed FullText FullText_MUG

 

Herrmann, M; Taban-Shomal, O; Müller, S; Gunter, L; Hübner, U; Böhm, M; Herrmann, W Hyperhomocysteinemia--the biochemical link between a weak heart and brittle bones?
Clin Lab. 2006; 52(3-4):137-147
Web of Science PubMed

 

Milting, H; Scholz, C; Arusoglu, L; Freitag, M; Cebulla, R; Jaquet, K; Körfer, R; V Lewinski, D; Kassner, A; Brodde, OE; Kögler, H; El Banayosy, A; Pieske, B Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.
J Mol Cell Cardiol. 2006; 41(3):441-450 Doi: 10.1016/j.yjmcc.2006.04.010
Web of Science PubMed FullText FullText_MUG

 

Schillinger, W; Teucher, N; Christians, C; Kohlhaas, M; Sossalla, S; Van Nguyen, P; Schmidt, AG; Schunck, O; Nebendahl, K; Maier, LS; Zeitz, O; Hasenfuss, G High intracellular Na+ preserves myocardial function at low heart rates in isolated myocardium from failing hearts.
Eur J Heart Fail. 2006; 8(7): 673-680. Doi: 10.1016/j.ejheart.2006.01.013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Beer, M Cardiac spectroscopy: techniques, indications and clinical results
Eur Radiol. 2004; 14(6):1034-1047 Doi: 10.1007/s00330-004-2279-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Schmidt, AG; Haghighi, K; Frank, B; Pater, L; Dorn, GW; Walsh, RA; Kranias, EG Polymorphic SERCA2a variants do not account for inter-individual differences in phospholamban-SERCA2a interactions in human heart failure.
J Mol Cell Cardiol. 2003; 35(7): 867-870. Doi: 10.1016/S0022-2828(03)00111-1
Web of Science PubMed FullText FullText_MUG

 

2002

Domej, W; Tilz, GP; Földes-Papp, Z; Demel, U; Rabold, T; Holzer, H Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies.
Clin Sci (Lond). 2002; 102(3):373-380 Doi: 10.1042%2FCS20010168 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schmidt, AG; Zhai, J; Carr, AN; Gerst, MJ; Lorenz, JN; Pollesello, P; Annila, A; Hoit, BD; Kranias, EG Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.
Cardiovasc Res. 2002; 56(2): 248-259. Doi: 10.1016/S0008-6363(02)00541-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2001

Haghighi, K; Schmidt, AG; Hoit, BD; Brittsan, AG; Yatani, A; Lester, JW; Zhai, J; Kimura, Y; Dorn, GW; MacLennan, DH; Kranias, EG Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.
J Biol Chem. 2001; 276(26): 24145-24152. Doi: 10.1074/jbc.M102403200 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sato, Y; Schmidt, AG; Kiriazis, H; Hoit, BD; Kranias, EG Letter to the editor: Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ release.
J Mol Cell Cardiol. 2001; 33(9): 1757-1759. Doi: 10.1006/jmcc.2001.1430
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum